A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma

by Wei Peng, MS, Si Li, PhD, Lijian Li, PhD, Mingzhe Xiao, PhD, Jincai Zhong, MD
Published 2021-01-01